Table 2.
Serum levels of GM-CSF in human patients with EBV infection or uninfected. Human GM-CSF antibody was used to evaluate its amount in human patients by ELISA assay. The data are expressed as the mean value in each patient.
| Patient No. | Infection | Disorder | hGM-CSF※(pg/ml) |
|---|---|---|---|
| P1 | + | HLH | 57.2 |
| P2 | + | HLH | 11.0 |
| P3 | + | HLH | 22.6 |
| P4 | + | HLH | 18.9 |
| P5 | + | HLH | 13.0 |
| P6 | + | HLH | 12.4 |
| P7 | + | HLH | 360.0 |
| P8 | + | PTLD | 23.0 |
| P9 | + | PTLD | 23992.0 |
| P10 | + | PTLD | 2707.0 |
| P11 | + | PTLD | 4895.0 |
| P12 | + | PTLD | 96.8 |
| C1 | − | sJIA | 7.1 |
| C2 | − | sJIA | 7.8 |
| C3 | − | KD | 3.4 |
| C4 | − | KD | 8.5 |
| C5 | − | KD | 4.6 |
| C6 | − | KD | 2.4 |
※As determined by hGM-CSF specific ELISA.